Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
643 |
|
| Actual shortage: | 17 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 541 (84%) | |
Discontinuation Reports |
233 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 233 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
80 (9%) |
|
Overdue reports |
1 (6%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Resolved | 2020-05-12 | 2020-05-26 | 114859 |
| MYLAN-CINACALCET | 60MG | TABLET | Resolved | 2020-05-12 | 2020-09-02 | 114862 |
| MYLAN-LAMOTRIGINE | 25MG | TABLET | Resolved | 2020-05-20 | 2020-05-26 | 115383 |
| MYLAN-LAMOTRIGINE | 150MG | TABLET | Resolved | 2020-06-03 | 2020-06-26 | 116446 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Resolved | 2020-06-03 | 2020-06-17 | 116453 |
| MYLAN-CINACALCET | 30MG | TABLET | Resolved | 2020-06-19 | 2020-09-30 | 118385 |
| MYLAN-GALANTAMINE ER | 16MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-06-30 | 2020-08-26 | 119216 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 375MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2020-07-02 | 2020-10-01 | 119316 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2020-07-08 | 2020-10-14 | 119721 |
| RIMSO-50 | 500MG | SOLUTION | Resolved | 2020-07-17 | 2020-10-28 | 120533 |
| MYLAN-VERAPAMIL SR | 180MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-21 | 2021-03-17 | 120686 |
| MYLAN-VERAPAMIL SR | 240MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-28 | 2020-12-01 | 121246 |
| MYLAN-ELETRIPTAN | 40MG | TABLET | Resolved | 2020-08-04 | 2020-09-22 | 121654 |
| MYLAN-CLOBETASOL SCALP APPLICATION | 0.05% | LOTION | Resolved | 2020-08-13 | 2020-11-10 | 122091 |
| MYLAN-MIRTAZAPINE | 15MG | TABLET | Resolved | 2020-09-01 | 2020-09-10 | 123514 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-10-06 | 2022-08-25 | 125767 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 375MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2020-10-15 | 2021-03-17 | 126398 |
| MYLAN-ELETRIPTAN | 40MG | TABLET | Resolved | 2020-11-17 | 2021-02-04 | 128484 |
| MYLAN-PROPAFENONE | 150MG | TABLET | Resolved | 2020-12-01 | 2021-04-19 | 129179 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 500MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2020-12-01 | 2021-02-03 | 129187 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |